In vitro effect of current antimalarial drugs on the survival of paired Schistosoma mansoni adult worms and their egg production

Tropical Medicine and Health

Volumn 38, Issue 2, 2010, Pages 69-73

  Mitsui, Yoshinori ^a   Aoki, Yoshiki ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Amodiaquine; Antimalarial drugs; Antischistosomal drugs; Chloroquine; Mefloquine; Primaquine; Pyrimethamine; Quinine; Schistosoma mansoni; Sulfadiazine

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ANTISCHISTOSOMAL AGENT; ARTEMISININ; ARTESUNATE; CHLOROQUINE; MEFLOQUINE; PRIMAQUINE; PYRIMETHAMINE; QUININE; SULFADIAZINE;

ANTIMALARIAL ACTIVITY; ARTICLE; EGG PRODUCTION; IN VITRO STUDY; INCUBATION TIME; MALARIA; NONHUMAN; PARASITE SURVIVAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SURVIVAL TIME; WORM;

EID: 77954667579     PISSN: 13488945     EISSN: 13494147     Source Type: Journal    
DOI: 10.2149/tmh.2010-04     Document Type: Article

References (24)

1. Steinmann P, Keiser J, Bos R. et al. Schistosomiasis and water resources development: systematic review, metaanalysis, and estimates of people at risk. Lancet Infect Dis 2006;6:411-425.
2. World Health Organization. Prevention and control of schistosomiasis and soil-transmitted helminthiasis, Report of a WHO expert committee. WHO Technical Report Se-riesNo. 912. Geneva, WHO: 2002.
3. Guisse F, Polman K, Stelma FF, et al. Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in Northern Senegal. Am JTropMedHyg 1997; 56: 511-514.
4. Ismail M, Botros S, Metwally A, et al. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 1999; 60: 932-935.
5. Utzinger J, Keiser J, Shuhua X, et al. Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. Antimicrob Agents Chemother 2003; 47: 1487-1495.
6. Xiao SH. Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artem-isinins. Acta Trop 2005; 96: 153-167.
7. Xiao SH, Catto BA. In vitro and in vivo studies of the effect of artemether on Schistosoma mansoni. Antimicrob Agents Chemother 1989; 33: 1557-1562.
8. Mitsui Y, Miura M, Aoki Y. In vitro effects of artesunate on the survival of worm pairs and egg production of Schis-tosoma mansoni. JHelminthol 2009; 83: 7-11.
9. Xiao SH, Keiser J, Chollet J, et al. In vitro and in vivo activities of synthetic trioxolanes against major human schis-tosome species. Antimicrob Agents Chemother 2007; 51: 1440-1445.
10. Abdulla MH, Lim KC, Sajid M, et al. Schistosomiasis mansoni:novel chemotherapy using a cysteine protease inhibitor. PLoS Med 2007; 4: e14.
11. Sayed AA, Simeonov A, Thomas CJ, et al. Identification of oxadiazoles as new drug leads for the control of schistos-omiasis. NatMed 2008; 14: 407-412.
12. Boulanger D, Dieng Y, Cisse B, et al. Antischistosomal efficacy of artesunate combination therapies administered as curative treatments for malaria attacks. Trans R Soc Trop Med Hyg 2007; 101: 113-116.
13. Adam I, Elhardello OA, Elhadi MO, et al. The antischis-tosomal efficacies of artesunate-sulfamethoxypyrazine-pyrimethamine and artemether-lumefantrine administered as treatment for uncomplicated, Plasmodium falciparum malaria. Ann Trop Med Parasitol 2008; 102: 39-44.
14. Mohamed AA, Mahgoub HM, Magzoub M, et al. Artesu-nate plus sulfadoxine/pyrimethamine versus praziquantel in the treatment of Schistosoma mansoni in eastern Sudan. Trans R Soc Trop Med Hyg 2009; 103: 1062-1064.
15. Keiser J, Chollet J, Xiao SH, et al. Mefloquine-an aminoal-cohol with promising antischistosomal properties in mice. PLoS Negl TropDis 2009; 3: e350.
16. Xiao SH, Mei JY, Jiao PY. The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma ja-ponicum. Parasitol Res 2009; 106: 237-246.
17. Snow RW, Guerra CA, Noor AM, et al. The global distribu-tion of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434: 214-217.
18. Smithers SR, Terry RJ. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 1965; 55: 695-700.
19. Oliveira MF, DAvila JC, Tempone AJ, et al. Inhibition of heme aggregation by chloroquine reduces Schistosoma mansoni infection. J Infect Dis 2004; 190: 843-52.
20. Winstanley P, Edwards G, Orme M, et al. The disposition ofamodiaquine in man after oral administration. Br JClin Pharmacol 1987; 23: 1-7.
21. Sisoko MS, Dabo A, Traore H. et al. Efficacy of artesunate + sulfamethoxypyrazine/pyrimethamine versus praziquantel in the treatment of Schistosoma haematobium in children. PLoS One 2009; 4: e6732.
22. World Health Organization. Guidelines for the Treatment of Malaria. Geneva, WHO: 2006. Available at: http://www.who.int/malaria/docs/TreatmentGuidelines2006.pdf. Accessed on Feb. 10, 2010.
23. Taylor WR, White NJ. Antimalarial drug toxicity: a review. DrugSaf 2004; 27: 25-61.
24. AlKadi HO. Antimalarial drug toxicity: a review. Chemo-therapy 2007; 53: 385-91.